Show simple item record

dc.contributor.authorMcDonald, Fen_US
dc.contributor.authorHanna, GGen_US
dc.coverage.spatialEnglanden_US
dc.date.accessioned2018-02-13T16:40:26Z
dc.date.issued2018-01en_US
dc.identifierhttps://www.ncbi.nlm.nih.gov/pubmed/29153859en_US
dc.identifierS0936-6555(17)30455-7en_US
dc.identifier.citationClin Oncol (R Coll Radiol), 2018, 30 (1), pp. 1 - 4en_US
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1055
dc.identifier.eissn1433-2981en_US
dc.identifier.doi10.1016/j.clon.2017.10.013en_US
dc.format.extent1 - 4en_US
dc.languageengen_US
dc.language.isoengen_US
dc.titleOligoprogressive Oncogene-addicted Lung Tumours: Does Stereotactic Body Radiotherapy Have a Role? Introducing the HALT Trial.en_US
dc.typeJournal Article
dcterms.dateAccepted2017-10-09en_US
rioxxterms.versionofrecord10.1016/j.clon.2017.10.013en_US
rioxxterms.licenseref.startdate2018-01en_US
rioxxterms.typeJournal Article/Reviewen_US
dc.relation.isPartOfClin Oncol (R Coll Radiol)en_US
pubs.issue1en_US
pubs.notesNot knownen_US
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Thoracic Radiotherapy
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Thoracic Radiotherapy/Thoracic Radiotherapy (hon.)
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublisheden_US
pubs.volume30en_US
pubs.embargo.termsNot knownen_US
icr.researchteamThoracic Radiotherapyen_US
dc.contributor.icrauthorMcDonald, Fionaen_US
dc.contributor.icrauthorMarsden,en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record